Replies to post #16230 on AEterna Zentaris Inc. (AEZS)

[livendi]

give it some time,after all novo took over in n america and we have eu license in hand already and 3 pedi trials alsogoing on in usa,eu and asia.also macrilen will be used for more than just a test.novo didnt pay 180 mill for n america rts for nothing.nothing but upside here.oh ya,the new ceo is an md who helped create macrilen and knows its many potential uses.novo or whoever is going to have to pay a decent price for aezs and macrilen or we will sell it ourselves in other coutries and especially eu where new ceo is centered and has many connections there